Data as of Aug 29
| +0.01 / +0.06%|
The 9 analysts offering 12-month price forecasts for Healthways Inc have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 9.00. The median estimate represents a -2.63% decrease from the last price of 17.46.
The current consensus among 11 polled investment analysts is to Buy stock in Healthways Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.